Amalgamated Bank’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $993K | Buy |
7,226
+26
| +0.4% | +$3.57K | 0.01% | 1044 |
|
|
2025
Q1 | $1.3M | Sell |
7,200
-236
| -3% | -$42.5K | 0.01% | 935 |
|
|
2024
Q4 | $1.17M | Buy |
7,436
+2
| +0% | +$313 | 0.01% | 1002 |
|
|
2024
Q3 | $1.35M | Sell |
7,434
-143
| -2% | -$26K | 0.01% | 952 |
|
|
2024
Q2 | $1.39M | Buy |
7,577
+6,847
| +938% | +$1.26M | 0.01% | 954 |
|
|
2024
Q1 | $130K | Sell |
730
-2,373
| -76% | -$423K | ﹤0.01% | 1681 |
|
|
2023
Q4 | $385K | Sell |
3,103
-217
| -7% | -$26.9K | ﹤0.01% | 1542 |
|
|
2023
Q3 | $385K | Buy |
3,320
+41
| +1% | +$4.76K | ﹤0.01% | 1538 |
|
|
2023
Q2 | $385K | Buy |
3,279
+777
| +31% | +$91.2K | ﹤0.01% | 1560 |
|
|
2023
Q1 | $200K | Sell |
2,502
-523
| -17% | -$41.8K | ﹤0.01% | 1803 |
|
|
2022
Q4 | $240K | Buy |
3,025
+81
| +3% | +$6.43K | ﹤0.01% | 1788 |
|
|
2022
Q3 | $205K | Buy |
2,944
+70
| +2% | +$4.87K | ﹤0.01% | 1839 |
|
|
2022
Q2 | $189K | Buy |
2,874
+437
| +18% | +$28.7K | ﹤0.01% | 1900 |
|
|
2022
Q1 | $162K | Buy |
+2,437
| New | +$162K | ﹤0.01% | 2023 |
|